MD, Assistant Professor, Medical Lead of the KORA Digital-Fit Intervention Study, Research Groups “Exposomics” & “Environmental Risks”

+49 89 3187 48701 Katharina.lechner@helmholtz-munich.de

Building / Room: 56, 235a

"The societal impact of reduced healthspan is profound. As a cardiologist, I am committed to helping individuals stay healthier for longer. As a scientist, I am passionate about better understanding the determinants of healthspan. The current focus of my work is to investigate scalable and personalized prevention frameworks for potential use in public health.”

Visit the research website

Katharina holds the position of medical lead for the life-course informed, digitally supported, person-centred KORA Digital-Fit intervention study. KORA Digital-Fit aims to prevent multimorbidity in ageing and is part of the European research and innovation project Stay Healthy Through Ageing (STAGE). During her medical training at LMU Klinikum, Präventive Sportmedizin und Sportkardiologie at TUM, and the Deutsches Herzzentrum München, Katharina specialized in preventive cardiology and lipidology. She is an EECC- and board-certified cardiologist and furthermore board-certified in internal medicine. Her scientific research focuses on understanding modifiable determinants of healthspan, as well as their interactions with genes.

Cardiology Lipidology Hypertension Cardiovascular Risk Factors Lifestyle Risk Factors Metabolic Health Personalized Prevention

2024

2023

2022

2020

2013

Abstract Award for Clinical Lipid Research of the German Cardiac Society 2022

Lechner K, Kia S, von Korn P*, Dinges SM, Mueller S, Tjønna AE, Wisløff U, Van Craenenbroeck EM, Pieske B, Adams V, Pressler A, Landmesser U, Halle M, Kränkel N.

Cardiometabolic and immune response to exercise training in patients with metabolic syndrome: retrospective analysis of two randomized clinical trials.

Lechner K, Bock M, von Schacky C, Scherr J, Lorenz E, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F.

Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial.

Lechner K, Scherr J, Lorenz E, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F.

Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial.

Lechner K, Lechner B, Crispin A, Schwarz PEH, von Bibra H.

Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance.

Lechner K, McKenzie AL, Kränkel N, Von Schacky C, Worm N, Nixdorff U, Lechner B, Scherr J, Weingärtner O, Krauss RM.

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.

Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, Kränkel N, Halle M, Krauss RM, Scherr J.

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.